Lake Street has decided to maintain its Buy rating of Evogene (NASDAQ:EVGN) and raise its price target from $2.00 to $3.00.
Shares of Evogene are trading up 1.01% over the last 24 hours, at $0.64 per share.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased